QuickView for CDK5;jsessionid=DF00B73361DF4175895E59E85F89AE6E;jsessionid=CDF09B32F89FC08DBAA56A3C79FCE510;jsessionid=8585292B40508051D8C2D7C237B64F59;jsessionid=7B101BC0A3E129AA1CE70FE51B37D9B4;jsessionid=61307583FA7433AA8A230EBDA6606920 (gene)

1. Cyclin-dependent kinase 5 (CDK5) inhibitors in Parkinson disease.
2. Phosphorylation of PBK at Thr9 by CDK5 correlates with invasion of prolactinomas.
3. Maintaining Drosha expression with Cdk5 inhibitors as a potential therapeutic strategy for early int…
4. Novel Medicinal Chemistry Strategies Targeting CDK5 for Drug Discovery.
5. Activation of cyclin-dependent kinase 5 broadens action potentials in human sensory neurons.

There were no clinical trials for CDK5;jsessionid=DF00B73361DF4175895E59E85F89AE6E;jsessionid=CDF09B32F89FC08DBAA56A3C79FCE510;jsessionid=8585292B40508051D8C2D7C237B64F59;jsessionid=7B101BC0A3E129AA1CE70FE51B37D9B4;jsessionid=61307583FA7433AA8A230EBDA6606920